Morocco Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oil & Tinctures) And By Application (Chronic Pain, Tourette’s, Arthritis, Diabetes, Glaucoma, Migraines),- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2034

Morocco Medical Cannabis Market Size and Research

The Morocco medical cannabis market size was exhibited at USD 157.40 million in 2024 and is projected to hit around USD 3,911.17 million by 2034, growing at a CAGR of 42.9% during the forecast period 2024 to 2034.

Morocco Medical Cannabis Market Key Takeaways:

• By product, the flower segment held the largest market share in 2024 and is expected to grow at the fastest CAGR of 44.0% over the forecast period.
• The oils & tinctures segment is expected to grow at a significant CAGR over the forecast period.
• By application, the chronic pain held largest market share of 23.9% in 2024.
• The Tourette's syndrome segment is expected to grow at the fastest CAGR over the forecast period.

Report Scope of Morocco Medical Cannabis Market

The growth of the industry in the country is driven by several factors, including the increasing legalization of medical marijuana in the country, the growing demand for alternative treatments for chronic diseases, and the country's longstanding reputation as a major producer of cannabis. In addition, the Moroccan government has undertaken steps to regulate and legalize its cultivation, encouraging investment and growth in the industry. For instance, in May 2021, the Moroccan Parliament adopted Bill 13-21 to regulate the cannabis plant for industrial and medical purposes.

With the recent legalization of medical cannabis in the country, there has been a growing interest in establishing a legal cannabis market. Morocco's reputation for cannabis has made it an attractive destination for tourists. According to High Times and South China Morning Post, Morocco is increasingly becoming a hotspot for marijuana tourism, with traditional hashish cafes, cannabis plantations, and markets being popular attractions. The country's cannabis industry has been estimated to be worth billions of dollars and legalizing it for recreational use could bring in substantial tax revenue and create job opportunities.

A significant driver of the legal cannabis market in Morocco is the growing need for medical marijuana, particularly for treating chronic ailments such as cancer, epilepsy, multiple sclerosis, and chronic pain. Research has shown that cannabis effectively treats various medical conditions. As more countries legalize medical marijuana, the global demand for the drug continues to grow. In addition, Morocco's favorable climate and low labor costs make it an attractive location for cannabis cultivation. The country has a long history of growing cannabis, and many farmers have vast experience in cultivation. For instance, according to the National Agency for the Regulation of Activities relating to Cannabis (ANRAC), after the legalization of cannabis cultivation and export for industrial and medical uses, Morocco's first legal cannabis harvest was 294 metric tons in 2023. Thus, Morocco is well-placed to become the leading producer of medical marijuana for export to other countries. 

Legalizing medical marijuana in Morocco drives the legal cannabis market by eliminating the black market for illegal cannabis products. The government regulates the production, distribution, and sale of cannabis products, ensuring that consumers have access to safe and regulated products, which improve public health and safety. Furthermore, legalization provides business opportunities for the cannabis industry in the country. For instance, in March 2023, Bio Cannat, the first Moroccan cooperative licensed to export and market cannabis and its products for medical and industrial purposes, began constructing its first laboratory. 

Furthermore, the use of medical marijuana has quickly gained popularity in Morocco after its recent legalization. Treatment with medical marijuana benefits people suffering from chronic illnesses and pains associated with cancer, arthritis, Alzheimer's disease, Parkinson's disease, depression, anxiety, and epilepsy. As a result, the widespread application of medical marijuana has contributed to its increased adoption for treating various chronic conditions.

Morocco Medical Cannabis Market By Product Insights

By product, the flower segment held the largest market share in 2024 and is expected to grow at the fastest CAGR of 44.0% over the forecast period. Dried cannabis flowers are used for smoking and obtaining the medical benefits of cannabis. Traditionally, they have been used to alleviate chronic pain, limit the growth of cancer, and slow down the progression of Alzheimer’s disease. Moreover, smoking cannabis is much more economical than purchasing oral products or tinctures; thus, most people prefer smoking. In addition, the onset of action posts the smoking of cannabis is rapid. Such factors fuel the segment growth. 

The oils & tinctures segment is expected to grow at a significant CAGR over the forecast period. The increasing number of patients requiring treatment for conditions such as epilepsy, PTSD, autism, chronic pain, muscle spasms resulting from multiple sclerosis, Parkinson's disease, and convulsions are expected to drive the demand for the oils & tinctures segment. Oils and tinctures provide convenient and discreet consumption methods, aligning with the growing demand for these products in domestic and international markets. In addition, regulatory changes and the economic opportunities presented by the industry contribute to the expansion of the oil and tincture segment, positioning Morocco as a key player in this rapidly evolving market. For instance, RIAD ZITOUN, a provider and manufacturer of beauty & wellness products, offers Pure Moroccan Cannabis Seed Oil, a nutritious oil for skin & hair.

Morocco Medical Cannabis Market By Application Insights

By application, the chronic pain held largest market share of 23.9% in 2024. The growth of the segment is attributed to research indicating the beneficial effects of marijuana in mitigating pain and the significant incidence of chronic pain. There is a shift from traditional treatment options for the use of medical cannabis in pain management due to the positive effects and cost-effectiveness provided by cannabis-based products in the country. Furthermore, cannabis has provided patients with long-term pain relief without significant adverse side effects. The co-administration of cannabis and opioids has been found to enhance pain relief. Many patients with chronic pain and other conditions have been found to taper or eliminate their prescription pain medications following the use of cannabis.

The Tourette's syndrome segment is expected to grow at the fastest CAGR over the forecast period, owing to an increasing number of patients exploring the potential benefits of marijuana-based treatments. With the growing acceptance and legalization of medical marijuana, patients in Morocco are seeking alternative and complementary treatments, leading to a rise in demand for these products specifically tailored for managing Tourette's syndrome. The expanding availability of these products and the potential improvements in the quality of life they offer make the Tourette's syndrome segment a significant focus within the market.  

Some of the prominent players in the morocco medical cannabis market include:

• Bio Cannat
• PharmaCielo.com.
• RIAD ZITOUN

Morocco Medical Cannabis Market Recent Developments

• In June 2024, Morocco introduced the sale of legal cannabis-based cosmetic products and dietary supplements in pharmacies.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the morocco medical cannabis market

By Product

• Flower
• Oil & Tinctures

By Application

• Cancer
• Chronic Pain
• Depression and Anxiety
• Arthritis
• Diabetes
• Glaucoma
• Migraines
• Epilepsy
• Multiple Sclerosis
• AIDS
• Amyotrophic Lateral Sclerosis
• Alzheimer’s
• Post-Traumatic Stress Disorder
• Parkinson's
• Tourette’s